Previous radiotherapy (RT) to the skull [5] or neurofibromatosis type II (NF II) with germline mutations in the NF II gene coding for the tumour suppressor merlin on chromosome 22q have been identified as risk factors for the development of meningiomas [6, 7]. The gene discussed is NF2; the disease is meningioma.